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Abstract
Generation of hepatocyte from embryonic stem cells (ESCs) holds great promise for hepatocyte replacement therapy to
treat liver diseases. Achieving high efficiency of directed differentiation of ESCs to hepatocyte is of critical importance.
Previously, Wnt3a has been reported to promote Activin A-induced human definitive endoderm (DE) differentiation, the
early stage of hepatocyte differentiation. However, the underlying molecular mechanisms are not clear. Growing evidence
demonstrated that microRNAs (miRNAs) are key regulators involved in various important biological processes including the
regulation of stem cell differentiation. In the present study, we profiled genome wide miRNA expression during Wnt3a and
Activin A induced mouse DE differentiation. We uncovered distinct miRNA expression patterns during DE differentiation
with the identification of a subset of miRNAs whose expression is synergistically regulated by Wnt3a/Activin A treatment at
different stages of DE differentiation. Forced expression of a pool of such synergistically regulated miRNAs alone could
partially promote DE differentiation, indicating a regulatory role of them. Using TargetScan and GeneGO pathway analyses,
the synergistically regulated miRNAs are predicted to regulate key pathways involved in DE differentiation; among them
includes the regulation of histone acetylation. Consistently, Wnt3a and Activin A treatment increased global histone
acetylation which can be partially mimicked by over expression of the pooled miRNAs. Chromatin IP (ChIP) experiments
demonstrated that the promoter regions of Sox17 and Foxa2 are subjected to histone acetylation regulation. Administration
of Hdac inhibitors greatly augmented DE differentiation. Our data uncovered a novel epigenetic mechanism of Wnt3a and
Activin A induced DE differentiation, whereby the treatment of growth factors induced histone acetylation at least in part by
the regulation of miRNA expression.
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Introduction
Diseases like cirrhosis and cancer caused liver injuries usually
lead to liver dysfunction and/or organ failure. Liver transplanta-
tion is so far the only effective treatment for liver cancer/failure or
other end stage liver diseases [1]. Shortage of donor organs has
limited its clinical applications. Treating liver cancer and other
liver diseases remains a major unmet medical need. Hepatocyte
transplantation has emerged as a promising alternative to liver
transplantation for treating liver diseases. However, such cell
replacement therapy is greatly hindered by the limited availability
of functional human hepatocyte suitable for transplantation.
Hepatocytes are also widely used in drug toxicity screen. There-
fore, establishing and understanding the mechanism of hepato-
genic differentiation paradigm is not only scientifically interesting,
but also clinically important.
The potential of ESCs to differentiate into cell types of a variety
of organs has generated much excitement for regenerative me-
dicine. Of great interests are DE derived organs, such as liver and
pancreas. Although several hepatocyte differentiation platforms
have been reported [2–5], the underlying mechanisms are not fully
understood. Activin A, the member of transforming growth factor
(TGF)-beta super-family, is known to play key roles in directing
ESC differentiation into DE, the early stage of hepatocyte
differentiation [6]. In addition, other factors such as members of
Wnt signaling pathway also play important roles in DE formation;
disruption of the Wnt signaling pathways prevents endoderm
formation during mouse embryo development [7,8]. In vitro,
Wnt3a signaling is also reported to be required for efficient differ-
entiation of human ESCs to functional hepatic endoderm induced
by Activin A, suggesting Wnt3a can improve the efficiency of
Activin A-induced DE differentiation [9]. However, the detailed
mechanisms for the synergistic effect are not understood.
microRNAs (miRNAs) are endogenous, short (about 22-
nucleotide) noncoding RNAs, known to regulate the expression
of target genes by degrading the target mRNA transcripts and/or
by inhibition of mRNA translation [10]. Up to 30% of human
genes are predicted to be regulated by miRNAs [11], suggesting a
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post-transcriptional level. In vivo, recent reports revealed that
embryonic development was accompanied by dynamic expression
of miRNAs. miRNAs such as lin-4 and let-7 are critical for
temporal control of larval development in c.elegans [12,13]. In
mouse preimplantation development, a set of miRNAs are tightly
regulated during trophectoderm specification [14]. In vitro,
characterizations of miRNAs expression in mouse and in human
ESCs and ESCs-derived embryoid bodies have been recently
published and revealed two highly-expressed clusters [15–17].
Furthermore, DE specific miRNAs have been identified in human
ESC-derived endoderm cells [18,19]; suggesting that miRNAs
play important roles in DE differentiation.
In this report, we performed a genome-wide analysis of miRNA
expression in Activin A and Wnt3a-treated mouse ESCs during
the different stages of DE differentiation to identify candidate
miRNAs likely to be involved in Wnt3a and Activin A induced DE
formation. Our analysis exhibited a distinct miRNA expression
fingerprint. Furthermore, we found that forced expression of a
subset of synergistically regulated miRNAs could partially mimic
the roles of Wnt3a and Activin A. Pathway analyses also revealed
the involvement of histone acetylation in Activin A/Wnt3a-driven
DE differentiation, which is further confirmed by treating the cells
with small molecular weight Hdac inhibitors as well as ChIP
experiments. Our study established a regulatory cascade from
extracellular cytokine treatment to miRNA expression to histone
modification in cell nuclei during DE differentiation.
Materials and Methods
Cell culture
The mouse ES TCL-1 cells were derived from 129/SvJae mice
using the same protocol as previously described [20], which is
according to national and international guidelines. This procedure
was approved by the Animal Ethics Committee at Novartis
Institutes for Biomedical Research in Cambridge (approved
animal protocol 09 DMP 072). The passage number used here
ranged from 10 to 20. mESCs were maintained on mitomycin C-
treated MEF feeder layers in DMEM medium supplemented with
15% FBS, 1 mM L-glutamine, 1 mM nonessential amino acids,
0.1 mM beta-mercaptoethanol, 1% Penicillin/streptomycin (all
from Invitrogen, Carlsbad, USA), and 1000 unit/ml LIF (Milli-
pore, Billerica, USA) under a standard gas atmosphere of
humidified air/5% CO2.
Definitive endoderm and hepatocyte differentiation
Mouse ESCs were maintained on MEF feeder cells until they
reached about 80% confluence. Prior to differentiation, mouse
ESCs were passaged onto gelatin-coated plates for 1 hour to
remove feeders, and afterwards, ESCs were seeded at 80000 cells
per well on collagen-coated 6 well plate. After overnight culture,
cells were treated with 100 ng/ml Activin A (R&D system,
Minneapolis, USA), or 50 ng/ml Wnt3a (R&D system, Minneap-
olis, USA), or 100 ng/ml Activin A plus 50 ng/ml Wnt3a (R&D
system, Minneapolis, USA) in RPMI 1640 (Invitrogen, Carlsbad,
USA) supplemented with 1XB27 and 1X sodium butyrate
(Invitrogen, Carlsbad, USA) for 3 to 5 days for endoderm
differentiation. For hepatic induction, after 5 days of Activin A
plus Wnt3a treatment, the differentiated cells were cultured in
hepatocyte culture medium (HCM) (Lonza, Basel, Switzerland)
containing 30 ng/ml FGF4 (R&D system, Minneapolis, USA) and
20 ng/ml BMP2 (R&D system, Minneapolis, USA) for 5 days,
then the differentiated cells were further treated with 20 ng/ml
HGF (R&D system, Minneapolis, USA) in HCM for maturation.
Cells cultured in the same medium without growth factors were
used as the negative control. Through the entire culture period,
medium was replenished every day.
To assess the effects of Hdac inhibition on DE differentiation,
the mouse ESCs were treat the same as above, except TSA
(Sigma, St. Louis, USA) was added at the final concentration of 1–
10 nM to the differentiation medium. DMSO alone added sam-
ples were used as the negative control. Cells were harvested for
RNA isolation and IF analyses at different stages of differentiation.
RNA isolation and miRNAs profiling
ESCs were treated with 100 ng/ml Activin A, or 50 ng/ml
Wnt3a, or 100 ng/ml Activin A plus 50 ng/ml Wnt3a, and the
samples were collected at 1 day, 3 days, and 5 days after treatment,
respectively. Cells treated with the same medium without growth
factors were used as the negative controls for each time point. All
samples were lysed in Trizol and RNA was extracted using the
procedure recommended by the manufacture (Invitrogen, Carls-
bad, USA) and DNA containment was removed using DNase di-
gestion. RNA quality was confirmed by Agilent bioanalyzer 2100.
Agilent miRNA arrays were performed in one color according
to the manufacturer’s instructions at Shanghai Biochip Corpora-
tion, China (Agilent Technologies, Santa Clara, USA). Data were
acquired using Agilent Feature Extraction software version 9.5.3.1.
To normalize the data across different arrays, quantile normal-
ization method was applied and all further analyses were carried
out using the normalized and background subtracted intensity
values [21,22]. Further data analyses were performed by using
GeneSpring GX 10.0, cluster 3.0, treeview and R. In brief, the
qualities of raw data were examined by hierarchal clustering and
principal component analysis (PCA) (Figure S1). Differentially
expressed miRNAs were identified by one-way ANOVA test
under following criteria (FDR,0.05, and Log2 difference.1or
,21, respectively). The synergistically regulated miRNAs were
identified using the following criteria: the miRNAs were up- or
down- regulated at least 1.5 fold in Activin A plus Wnt3a treated
samples compared to Activin A treated samples, while, the
miRNAs were not significantly regulated in Wnt3a alone treated
samples. The differentially expressed miRNAs were clustered
using cluster 3.0 and displayed using Treeview. For miRNAs
expression finger print analysis, the differentially expressed
miRNAs were re-normalized by using Z-score normalization in
spotfire, and then further clustered by 969 SOM in Genespring.
After that, for each sample, these miRNAs were averaged in each
cluster and presented by heatmap which respond to each cluster in
SOM. For pathway analysis, first, we predicted target genes of
synergistically regulated miRNAs using TargetScan version 5.1
and Miranda, and further used these genes as an input for
pathway analysis using GeneGO software [23]. All data in our
study is MIAME compliant and that the raw data has been
deposited in the National Center for Biotechnology Infor-
mation Gene Expression Omnibus repository (GEO accession
no. GSE29093).
Immunofluorescence (IF)
Cells were fixed in 4% paraformaldehyde in phosphate-buffered
saline (PBS) at room temperature for 20 minutes and treated with
0.5% Triton X-100 for 30 min, then washed with PBS for three
times, The fixed cells were blocked with PBS containing 3%
bovine serum albumin at room temperature for 1 hour. Cells were
incubated with primary antibodies at 4uC overnight. Normal
rabbit serum was used as a negative control, and no fluorescence
was observed in the negative controls. The primary anti-
bodies against Sox17 (R&D system, Minneapolis, USA) and
miRNA Profiling during DE Differentiation
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against Albumin (ABcam, Cambridge, England) and AFP (R&D
system, Minneapolis, USA) was diluted at 1:200, respectively.
After washes with PBS three times, FITC-conjugated or TRITC-
conjugated secondary antibody (Invitrogen, Carlsbad, USA)
diluted at 1:1000 was added and incubated at 37uC for 1 hour.
Then 1 ug/ml DAPI was used to stain the cell nuclei.
Real-time RT-PCR (RT-qPCR)
Real-time RT-PCR analysis was performed on an ABI Prism
7900 Sequence Detection System using the SYBR Green PCR
Master Mix and miRNA Taqman Master Mix (Applied
Biosystems, Foster City, USA), respectively. The PCR reaction
was performed as described [24]. The relative expression of each
gene was normalized against Gapdh, and the relative expression of
each miRNAs was normalized against U6 snRNA, respectively.
The primers and miRNAs probe number used for the quantitative
RT-PCR are shown in Table S1.
miRNAs over-expression
In order to over-express miRNAs in differentiating ESCs, six
synthetic mature miRNAs (Invitrogen), mir-181c/338-5p/222/
196a/196b/let-7e, were pooled together equivalently. Cel-miR-
67, which has been confirmed to have minimal sequence identity
with miRNAs in human, mouse and rat, was used as a negative
control. The final concentration of the pooled miRNAs and the
control miRNA (Cel-67) is 20 uM. Mono-layer ESCs were treated
with 100 ng/ml Activin A for three days in collagen coated 6-well
plate, then transfect with 10 ul pooled miRNAs by using 5 ul
RNAMAXi reagent (Invitrogen, Carlsbad, USA). The transfected
cells were allowed for further differentiation for 2 more days. At
day 5, the differentiating cells were transfected one more time with
10 ul of pooled miRNAs the same as above. 5 days after the initial
transfection, all the samples were collected and analyzed for DE
marker expression. The detailed protocol was described in
Methods S1.
Inhibition of miRNA expression by synthetic miRNA
inhibitors
In order to confirm the roles of the regulatory miRNAs in
Activin A and Wnt3a induced DE cell differentiation and histone
acetylation level, we over-expressed pooled miRNA inhibitors in
differentiating ESCs. The synthetic miRNA inhibitor experiment
was carried out essentially the same as that of the pooled miRNA
over-expression experiment. Six synthetic mature miRNA inhib-
itors including mir-181c/338-5p/222/196a/196b/let-7e were
pooled together equivalently. Cel-miR-67 inhibitor was used as a
negative control. All miRNAs inhibitors were synthesized by
Invitrogen (Carlsbad, USA). At the 5th day of differentiation, the
samples were collected and analyzed on DE markers and histone
acetylation levels.
Western blot analysis
Cells were lysed in 1XRIPA lysis buffer in the presence of
protease inhibitor mixture (Roche, Basel, Switzerland). To
determine protein concentration, the lysates were measured using
a Bio-Rad BCA protein assay (Bio-Rad, Richmond, USA), and
resolved on a 10% SDS-PAGE gel, then transferred to a
nitrocellulose membrane (Invitrogen, Carlsbad, USA). After
blocking with Superblock T20 Blocking buffer (Thermo scientific,
Waltham, USA), the membrane was incubated with a primary
antibody overnight at 4uC and then with a secondary antibody
conjugated with alkaline phosphatase (1 h at room temperature),
the signal was detected by using a chemiluminescence method.
The following polyclonal primary antibodies were used: anti-
human Sox17 (1:1000, R&D system, Minneapolis,USA), anti-
H3K9Ac (1:1500, Cell Signaling, Danvers, USA), anti-H3K27Ac
(1:1500, Cell Signaling, Danvers, USA), anti-Tubulin (1:10000,
Santa Cruz Biotechnology,California, USA).
Chromatin Immunoprecipitation PCR (ChIP-PCR)
Mouse ESCs were cultured in differentiation medium for 2 days
as mentioned above. The cells were then treated with fresh culture
medium containing 1% formaldehyde for 10 minutes, and washed
twice with ice cold PBS containing protease inhibitors. The cell
pellets were then re-suspended in SDS lysis buffer also containing
protease inhibitors (200 ml lysis buffer for every 1*10
6 cells) and
incubated on ice for 10 minutes. Cell lysate was sonicated (15w for
10 seconds for three times) to shear DNA to lengths between 200
and 1000 base pairs. The next ChIP experimental procedures
were performed following the protocol of chromatin Immunopre-
cipitation (ChIP) Assay Kit (Millipore17–295) using the antibody
against H3K9Ac (Cell Signaling, Danvers, USA). The eluted DNA
was used to assess the level of acetylated H3K9 recruited to Sox17
and Foxa2 promoters by PCR and qPCR. For each gene, the
primers were designed based on the sequence 1 kb to 2 kb
upstream of transcript initiation site. The sequences were listed in
Table S1.
Results
Wnt3a improves the efficiency of Activin A-induced DE
formation from mouse ESCs
DE has been successfully derived in vitro from mouse ESCs in
the culture condition of low serum and high concentration of
Activin A [25]. It has been shown previously that Wnt3a could
improve the efficiency of Activin A-induced DE differentiation
from human ESCs [9]. We hypothesized that Wnt3a might also
improve the efficiency of Activin A-induced DE formation in
mouse ESCs. To test this hypothesis, we treated mouse ESCs with
Activin A either in the presence or absence of Wnt3a. After
treatment in serum-free culture medium for 5 days, cells were
analyzed for their expression of specific DE markers (Sox17 and
Foxa2). Immunofluorescence (IF) staining revealed that about
80% of the cells treated with Activin A and Wnt3a expressed
Sox17 or Foxa2, while only about 40% of the cells were Sox17 or
Foxa2 positive when treated with Activin A alone (Figure 1A).
Wnt3a alone did not affect DE differentiation. RT-qPCR further
confirmed that the expression of Sox17 and Foxa2 was signi-
ficantly increased upon co-treatment with Activin A and Wnt3a,
while addition of Wnt3a alone did not induce DE formation from
mouse ESCs (Figure 1B). Activin A and Wnt3a co-treatment did
not significantly induce the expression of Nestin, Cdx2, Bmp4, or
mT (data not shown), suggesting that most of the differentiated
cells were not mesoderm or ectoderm cells. Together, our data
indicated that Wnt3a can augment mouse ESC derived DE
formation by acting synergistically with Activin A.
DE cells induced by Activin A and Wnt3a are competent
for hepatocyte differentiation
It has been shown that ESC-derived DE could further
differentiate into hepatocytes by treatment with FGFs, BMP and
HGF sequentially. We next addressed whether the mouse DE cells
induced by Activin A and Wnt3a are competent of hepatocyte
differentiation. The DE cells induced by Wnt3a/Activin A were
further treated with FGF4 and BMP2 for hepatic initiation, and
subsequently with HGF for hepatic maturation. After total 8 days
miRNA Profiling during DE Differentiation
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(Figure 2A); most of the differentiated cells expressed AFP and
Albumin by IF analysis (Figure 2B), indicating that these cells have
differentiated into hepatocyte-like cells. We further confirmed
their hepatic cell identity by examining the expression of other
known hepatocyte markers using RT-qPCR. We found that,
under the current differentiation conditions, the differentiated cells
are positive for various hepatocyte markers including Ck7, Ck18,
Ck19, Tat, G6p, and Hnf4 (Figure 2C). These results suggested
that mouse DE cells induced by Activin A and Wnt3a were
capable of differentiating into hepatocytes.
Characterization of miRNA expression fingerprint during
DE differentiation
We have shown that Wnt3a could act synergistically with
Activin A to induce mouse DE formation as they did to human
Figure 1. Wnt3a improves the efficiency of Activin A induced DE differentiation from mouse ESCs. The mouse ESC line, TCL-1 cells, were
treated with 100 ng/ml Activin A, 50 ng/ml Wnt3a, or 100 ng/ml Activin A plus 50 ng/ml Wnt3a, respectively. The differentiated cell samples were
collected 5 days after treatment for DE marker analyses by using IF and RT-qPCR. A. IF staining of Sox17 and Foxa2 expression in differentiated mouse
ESCs treated with different growth factors. Scale bar: 50 uM. B. RT-qPCR examination of the expression of DE markers, Sox17 and Foxa2. Data are
expressed as mean fold change 6 SD. A: Activin A; 3a:Wnt3a.
doi:10.1371/journal.pone.0027965.g001
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is unknown. Since it has been well established that miRNAs are
involved in various development and differentiation processes, we
asked whether the synergy between Wnt3a and Activin A in DE
differentiation involves the regulation of miRNAs. Previous studies
had uncovered some miRNAs expressed by human ESC-derived
DE cells [18,19]. We examined the expression of two of them, mir-
125a-5p and mir-let-7e, during mouse DE differentiation. The
result shows that they were also regulated by Activin A and Wnt3a
in mouse ESC derived DE differentiation (Figure S2). These two
miRNAs do not show significant synergistic expression pattern
upon Activin A and Wnt3a treatment.
To gain a comprehensive understanding of the effects of Wnt3a
and Activin A on miRNAs expression, we performed global
miRNA expression profiling using microarray. We treated mouse
ESCs with Activin A, Wnt3a or Activin A plus Wnt3a, and
collected the RNA samples at 1 day, 3 days and 5 days after
treatment, representing different stages of DE differentiation
(namely, DE initiation, DE progression, and DE maturation,
respectively). We used the Agilent miRNA microarrays for the
profiling study. ANOVA test showed that 386 miRNAs were
differentially expressed under the cutoff of FDR,0.05 among all
the treatment groups during Wnt3a/Activin A-induced DE
differentiation. The overall expression pattern of the differentially
expressed miRNAs was demonstrated by hierarchal clustering
analysis (Figure 3A). We further identified the differentially
regulated miRNAs respect to the various stages of differentiation.
At DE initiation, Only 4 miRNAs were significantly regulated
under the cutoff as FDR,0.05 and fold.2o r,0.5. While
differentiation proceeds, increasing number of miRNAs (90 miR-
NAs and 118 miRNAs for DE progression and maturation,
respectively) were differentially expressed (Figure 3B, C). In order
to confirm our microarray data, we selected a subset of miRNAs
and tested them by using Taqman RT-qPCR analysis using
independent RNA samples (Figure S3). The RT-qPCR results
were in good agreement with our microarray findings although the
fold changes were usually higher from the array data due to the
inherent technical difference between the two platforms.
To further explore miRNA expression pattern during DE
differentiation, differentially expressed miRNAs were analyzed by
using self-organizing map (SOM) and presented using a heatmap
visualization (Figure 3D). The results revealed that at DE initiation
the expression patterns of miRNAs of different treatment groups
were very similar; when differentiation proceeds, we observed
distinct miRNA expression patterns. The control and Wnt3a alone
treated samples shared a very similar miRNA expression pattern,
which was in agreement with that Wnt3a alone had little effect on
DE differentiation. However, Activin A and Activin A plus Wnt3a
treatment groups induced dramatic miRNA expression changes.
We next examined the molecular functions and the biological
relevance of some of the differentially expressed miRNAs within
various clusters of the SOM. mir-335 family members mir-335-3p
and mir-335-5p, two of the most significantly regulated miRNAs,
belong to cluster 32(C32) and cluster 41(C41), suggesting that they
may be mainly driven by spontaneous differentiation (Figure 3D).
On the other hand, some known miRNAs involved in DE-related
tissue development fall into distinct clusters likely driven by
Wnt3a/Activin A treatment (Figure 3D). For examples, mir-218
(C46) is dynamically expressed in developing liver and pancreas,
which targets Hepatocytes Nuclear Factor-6 (HNF-6/OC-1) and
OC-2 to regulate liver and pancreas development [26]. mir-375
(C48) is selectively expressed in pancreas, which targets 39-
phosphoinositide dependent protein kinase-1 and regulates glucose
induced biological responses in pancreatic beta-cells [27].
Identification of miRNAs synergistically regulated by
Wnt3a and Activin A
Some of the differentially expressed miRNAs might play
regulatory roles in DE differentiation, i.e., they play instructive
roles directing DE differentiation rather than being molecular
markers resulted from DE differentiation. We hypothesized that
the miRNAs showing synergistic pattern upon Wnt3a/Activin A
treatment might have a higher probability of being regulatory. We
applied the following criteria to select the synergistic miRNAs: the
miRNAs were up- or down- regulated at least 1.5 fold in Activin A
Figure 2. Hepatic differentiation of Activin A and Wnt3a induced mouse DE. Mouse DE cells induced by Activin A and Wnt3a were treated
with growth factors (GFs) for further differentiation into hepatocytes for 8 days. A. Morphology of differentiated cells with or without GFs. Please note
that the GF treated cells demonstrated typical hepatocyte like morphology. Scale bar: 50 uM. B. IF staining of AFP and Albumin (Alb) in differentiated
cells. Scale bar: 20 uM. C. RT-qPCR examination of hepatocyte marker expression in the differentiated cells. Data are expressed as mean fold change
6 SD. GF: 30 ng/ml FGF4, 20 ng/ml BMP2, 30 ng/ml HGF.
doi:10.1371/journal.pone.0027965.g002
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samples, while, they were not significantly regulated in Wnt3a
alone treated samples. Under such criteria, at DE initiation, no
miRNAs were synergistically regulated. While, at DE progression
10 miRNAs were synergistically regulated. In addition, mir-10a
which was down regulated in Activin A treated samples was
further down regulated in Activin A plus Wnt3a treated samples,
while it was up-regulated in Wnt3a treated sample. We considered
it as one synergistically regulated miRNA as well. Figure 4A
displays the expression pattern of these synergistically regulated
miRNAs at DE progression. Among these miRNAs, some of them,
such as mir-222, has been reported to regulate endoderm
differentiation [18]. In addition, we also identified some miRNAs,
which were not previously reported to regulate ESC derived
endoderm differentiation, such as mir-338-5p and mir-340-3p.
The potential roles of these miRNAs on promoting DE
differentiation warrant future investigation. At DE maturation,
20 miRNAs were found to be synergistically regulated (Figure 4B).
Very little synergistically regulated miRNAs were overlapped
between DE progression and maturation. Strikingly, many of these
synergistically regulated miRNAs were also found to be regulated
in hESCs derived DE [18] such as mir-196a, mir-196b, and miR-
24-2*, suggesting that the roles of miRNAs on DE differentiation
might be conserved between human and mouse.
MiRNAs have been reported to play roles in promoting and
directing cell differentiation. For example, miR-17-5p, miR-20a,
miR-93, and miR-106a, were found to be differentially expressed
in developing mouse embryos and function to control differenti-
ation of stem cells [28]. In light of this, we decided to test whether
forced expression of a subset of miRNAs we identified in the
current study could themselves affect the differentiation process.
We over-expressed a pool of miRNAs consisting mir-181c/338-
5p/222/196a/196b/let-7e at 3 days of differentiated ES cells and
then examined the DE markers 2 days later. The over-expressed
miRNA level was confirmed by using RT-qPCR (Figure S4). The
result revealed that all these miRNAs were significantly over-
expressed in differentiated cells. Moreover, the RT-qPCR results
indicated that the expression of Sox17 and Foxa2 were
significantly increased upon pooled miRNA over-expression
(Figure 5). The data suggested that forced expression of these
pooled miRNA could facilitate Activin A-induced DE differenti-
ation in a similar way to Wnt3a.
Figure 3. Differentially expressed miRNAs during DE differentiation from mouse ESCs. Mouse ESCs were treated with 100 ng/ml Activin
A, 50 ng/ml Wnt3a, or 100 ng/ml plus 50 ng/ml Wnt3a, and the samples were collected and profiled for miRNA expression at 1 day, 3 days, and 5
days after treatment. The differentially expressed miRNAs were identified by using ANOVA test under FDR ,0.05. A. 386 differentially expressed
miRNAs in all samples were presented using hierarchal clustering analysis. The miRNAs expression values were normalized by Z-score normalization,
and the hierarchal clustering was performed in Cluster3.0 using average linkage with Euclidean being used as the distance metrics. B, C. Hierarchal
clustering of 90 and 118 differentially expressed miRNAs under the cutoff as FDR ,0.05 and fold.2o r,0.5 in 3 day and 5 day samples, respectively.
D. 386 differentially expressed miRNAs identified by ANOVA were analyzed in Genespring using 969 SOM methods with Euclidean being used as the
distance metrics. Heatmap presented average expression pattern of the miRNAs in each cluster from SOM in different treatment groups. The position
of each cluster was presented as Cluster (Cij), i means row; j means column. For example, C32 means the cluster at the third row and second column.
Please note the distinct expression fingerprint of miRNAs during DE differentiation. The differentially expressed miRNAs for each time point were
listed in Table S2, S3, and S4, respectively. A: Activin A; 3a:Wnt3a.
doi:10.1371/journal.pone.0027965.g003
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In order to further explore the functions of the synergistically
regulated miRNAs, we predicted the putative target genes for
these miRNAs by using TargetScan 5.0 software, and then
performed functional enrichment test using GeneGO software. At
DE progression, several pathways were significantly enriched
(Table 1). Among the enriched pathways, TGF-beta signaling
pathway was the most significantly enriched one, consistent with
the known roles of SMAD2/3 in regulating endoderm differen-
tiation [29]. In addition, a few other known pathways involved in
classical endoderm differentiation such as HGF, IGF were also
significantly enriched, suggesting that they may also be subject to
miRNA regulation during Wnt3a and Activin A-induced DE
differentiation.
Notably, the Hdac-related pathway was the second most
significantly enriched one. Although studies reported that Hdac
is involved in ESC differentiation [30,31], whether Hdac is indeed
involved in Wnt3a and Activin A induced DE differentiation is not
known. At DE maturation stage, we also predicted target genes
for these candidate miRNAs. The results indicated that many
Figure 4. Synergistically regulated miRNAs by Wnt3a and Activin A during mouse DE formation. Synergistically regulated miRNAs were
identified using the criteria stated in the results section. The synergistically expressed miRNAs identified at day 3 (A) and day 5 (B) was presented
using the heatmap visualization. No miRNA was found to be synergistically regulated at day 1 samples under current cutoffs. A: Activin A; 3a:Wnt3a.
doi:10.1371/journal.pone.0027965.g004
Figure 5. Over-expression of pooled miRNAs partially increases the expression of DE markers. Mouse ESCs were treated with 100 ng/ml
Activin A for three days, then transfected with pooled miRNAs to allow further differentiation for 2 more days. Cel-miR-67 was use as a negative
control. The expression of two DE markers Sox17 and Foxa2 was analyzed by RT-qPCR. The expression of these two markers was significantly
increased after treating with pooled miRNAs as compared to the control cells (P=0.003 for Sox17, and P=0.028 for Foxa2). Data are expressed as
mean fold change 6 SD. A: Activin A.
doi:10.1371/journal.pone.0027965.g005
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were also significantly enriched during DE maturation (Table 2).
Besides the Hdac-related pathway, Sin3 and NuRD pathways
were also significantly enriched. Sin3 and NuRD are two members
that form complexes with Hdacs to regulate gene expression. We
further used Miranda to predict these miRNA target genes and
further used the predicted genes in the pathway analysis. Hdac
and related pathways could be also significantly enriched (data not
shown). Together, the data suggest that Hdac might play an
important role in DE formation.
RegulationofhistoneacetylationduringDEdifferentiation
In order to confirm the roles of Hdac in DE formation, we
checked histone H3 acetylation level during DE differentiation.
Treating the cells with Activin A resulted in increased histone
acetylation as manifested by western blot analyses on both histone
H3K9 and H3K27 acetylation (Figure 6A). Moreover, the increase
of histone acetylation is more significant when the cells were co-
treated with Activin A and Wnt3a. There is no significant change
of total histone (data not shown). Since the involvement of Hdac in
DE differentiation was identified through pathway analysis on
miRNA expression, we next asked if Wnt3a and Activin A induced
histone acetylation could be mediated through miRNA. We thus
over expressed the pooled miRNA as described above and
examined the histone acetylation level by western blot analysis.
The data demonstrated that forced expression of these miRNA
also partially increased histone acetylation (Figure 6B). To further
confirm the roles of these regulatory miRNAs, we tried to inhibit
the expression of the miRNAs by using synthetic miRNA
inhibitors during Activin A and Wnt3a induced DE differentia-
tion. When the cells were transfected with the pooled miRNA
inhibitors against the 6 regulatory miRNAs that have been tested
in the over-expression experiment, miRNA inhibitory efficiency
was further examined by using RT-qPCR (Figure S5). The result
shown that the increased histone acetylation level and DE marker
expression induced by Activin A and Wnt3a were attenuated
(Figure 6C). These data indicated that Wnt3a and Activin A
induced histone acetylation and DE differentiation could be at
least partially mediated through miRNAs.
Histone acetylation of the promoter regions of Sox17
and Foxa2
We next asked if the promoters of DE-specific transcription
factors could be direct targets of histone acetylation regulation. We
Table 1. The 10 most significantly enriched pathways at DE progression stage.
Name pValue Network objects
Development_TGF-beta receptor signaling 3.77E–12 19/50
Development_Role of HDAC and calcium/calmodulin-dependent kinase (CaMK) in control of skeletal myogenesis 1.86E–11 19/54
Cytoskeleton remodeling_TGF, WNT and cytoskeletal remodeling 2.08E–11 27/111
Cell adhesion_Ephrins signaling 6.09E–09 15/45
Development_Slit-Robo signaling 1.93E–08 12/30
Stem cells_Early embryonal hypaxial myogenesis 3.10E–08 13/37
Development_IGF-1 receptor signaling 4.17E–08 15/51
Signal transduction_Activin A signaling regulation 6.82E–08 12/33
Transcription_Role of heterochromatin protein 1 (HP1) family in transcriptional silencing 7.00E–08 10/22
Development_Alpha-1 adrenergic receptors signaling via cAMP 2.09E–07 9/19
Note: GeneGo pathway analysis of putative targeted genes of synergistically regulated miRNAs at Progression stage. The 10 most significantly
enriched pathways were listed in table1. The detailed enriched pathways were shown in Table S5.
doi:10.1371/journal.pone.0027965.t001
Table 2. The 10 most significantly enriched pathways at DE maturation stage.
Name pValue Network objects
Transcription_Sin3 and NuRD in transcription regulation 6.79E–11 16/38
Development_Thrombopoietin-regulated cell processes 1.25E–08 15/45
Cell cycle_ESR1 regulation of G1/S transition 1.22E–07 12/33
Stem cells_Self-renewal of adult neural stem cells 2.56E–07 14/48
Transcription_Ligand-dependent activation of the ESR1/SP pathway 3.76E–07 11/30
Cardiac Hypertrophy_NF-AT signaling in Cardiac Hypertrophy 4.70E–07 16/65
Development_PDGF signaling via STATs and NF-kB 8.00E–07 11/32
Signal transduction_Activin A signaling regulation 1.14E–06 11/33
Development_Role of HDAC and calcium/calmodulin-dependent kinase (CaMK) in control of skeletal myogenesis 1.25E–06 14/54
Development_HGF signaling pathway 1.35E–06 13/47
Note: GeneGo pathway analysis of putative targeted genes of synergistically regulated miRNAs at maturation stage. The 10 most significantly
enriched pathways were listed in table 2. The detailed enriched pathways were shown in Table S6.
doi:10.1371/journal.pone.0027965.t002
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assess the level of histone acetylation at the promoter regions of
Sox17 and Foxa2. The pluripotent marker Sox2 was also assessed
as a control. We surveyed 1 k, 2 k, and 50 k upstream of the
promoter regions of Sox17 and Foxa2. The results demonstrated
that acetylated H3K9 was indeed recruited to the promoter
regions of Sox17 (1 k and 2 k regions of the promoter) and Foxa2
(1 k, 2 k, and 50 k regions of the promoter) in both differentiated
and undifferentiated cells. Interestingly, H3K9ac level at 2 k
region of Sox17 and Foxa2 promoters were significantly higher in
Activin A and Wnt3a treated cells than that of the control cells by
ChIP-quantitative PCR analysis (Figure 6D). As the control, the
H3K9ac level at Sox2 promoter was significantly decreased upon
Activin A and Wnt3a treatment which is opposed to that of Sox17
and Foxa2. Since H3K9ac is an active histone marker, our data
suggested that the expression of key DE transcription factors like
Sox17 and Foxa2 is subject to transcription activation through
histone acetylation during Activin A and Wnt3a induced DE
formation.
Inhibition of Hdac activity promotes Activin A-induced DE
differentiation
In order to further explore which Hdac(s) might be involved in
regulating Activin A and wnt3a induced DE differentiation, we
checked which Hdac(s) could be targeted by the synergistic
miRNAs by using alignment analysis using miRNA consensus
sequences. The results showed four consensus binding sites for the
miRNAs (mi181C, 338-5p, 196a/b) in the Hdac9 39 UTR region.
There is also one consensus miRNA (338-5p) binding sequence for
Hdac7 at the 39 UTR after poly A signal region (Figure S6). We
next checked these Hdac expression in miRNA pooled over-
expressed differentiating cells. We found that Hdac9 not Hdac7
could be significantly down-regulated, suggesting that Hdac9
might be involved in mouse DE differentiation (Figure S7).
We further treated the cells with the Hdac inhibitor trichostatin
A (TSA) in our differentiation experiments. RT-qPCR and IF
staining were applied to assess DE differentiation 5 days after
treatment. The results revealed that TSA could significantly
increase the efficiency of Activin A induced DE differentiation
(Figure 7A and 7B), notably, under Activin A, Wnt3a and TSA co-
treatment, almost all of the cells are Sox17 positive. Using other
Hdac inhibitors, we obtained similar results (data not shown).
These data indicated that inhibiting Hdac activity does promote
DE differentiation from mouse ESCs.
Discussion
In order to understand the molecular mechanisms underlying
DE differentiation, we analyzed genome wide miRNA expression
in Activin A and Wnt3a-induced DE formation from mouse ESCs.
We applied various informatics approaches including SOM-based
clustering analysis to establish the miRNA expression fingerprint
of DE differentiation. We identified a subset of miRNAs whose
expression was synergistically regulated by Wnt3a and Activin A.
Forced expression of those synergistically regulated miRNAs
partially mimics the roles of Wnt3a, suggesting that they are likely
Figure 6. Involvement of histone acetylation in DE differentiation. A. Wnt3a increases H3K9/K27 acetylation level during DE differentiation.
Mouse ESCs were treated with Activin A and Wnt3a for 5 days and subjected to western blot analysis on histone H3 acetylation using antibodies
against H3K9ac and H3K27ac. Sox17 was examined to confirm DE differentiation. Tubulin was used as the loading control. B. Western blot analysis on
histone H3 acetylation using antibodies against H3K9ac and H3K27ac in pooled miRNA over-expressed DE samples. Tubulin was used as the loading
control. Please note that over-expression of a subset of miRNAs increases H3K9/K27 acetylation level. C. Western blot analysis on Sox 17 and histone
H3 acetylation using antibodies against H3K9ac and H3K27ac in pooled miRNA inhibitors over-expressed DE samples. Tubulin was used as the
loading control. D. the H3K9 acetylation level of Sox17, Foxa2, and Sox2 promoter regions was quantified by ChIP-qPCR. The data was normalized to
input; fold change values were labeled as indicated. Data are expressed as mean percentage 6 SD. A: Activin A; 3a:Wnt3a.
doi:10.1371/journal.pone.0027965.g006
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analyses revealed that several key pathways maybe regulated by
miRNA during DE differentiation. Among them includes the
Hdac pathway. Consistent with the miRNA profiling results,
Activin A and Wnt3a treatment increases the level of histone H3
acetylation, while inhibition of Hdac greatly enhances the DE
differentiation efficiency. ChIP analysis further revealed that the
key DE transcription factors are subject to transcription activation
through histone acetylation. Together, the present miRNA
profiling studies revealed novel epigenetic insights into DE
differentiation.
Wnt signaling stimulates numerous intracellular signal trans-
duction cascades to regulate stem cell self-renewal and differen-
tiation. In vivo, Wnt signaling plays an important role during
gastrulation [7,8]. Wnt-mediated Brachyury expression is also
important for the migration of precursor cells through the anterior
region of the primitive streak (PS). The subsequent specification of
the anterior region of the PS to mesoderm or endoderm is thought
to depend on the duration and magnitude of Nodal signaling
[9,32,33]. Following its commitment, the DE cells line the ventral
region of the developing embryo and are patterned by adjacent
mesenchyme. In vitro, inhibiting Wnt signaling can inhibit the
differentiation of mouse hepatic progenitor cells [34]. Our data
indicated that Wnt3a activates beta-catenin activity in mouse
ESCs during DE differentiation (not shown), and further affects
miRNA expression to facilitate Activin A-induced DE formation.
Particularly, when DE differentiation proceeds, we found that an
increased number of miRNAs were differentially regulated by
Wnt3a and Activin A co-treatment, suggesting that Wnt3a might
play more important roles in the late stages of DE formation. The
Figure 7. Inhibiting of histone de-acetylation by TSA. A. IF staining of Sox17 in control and 10 nM TSA treated differentiated samples. TSA was
added at the final concentration of 10 nM to the differentiation medium for five days. DMSO was added as the negative control. Please note that
addition of TSA greatly increases the DE differentiation efficiency. Scale bar: 50 uM. B. Sox17 and Foxa2 expression in cells treated with different doses
of TSA was examined by RT-qPCR. Mouse ESCs were treated the same as above, TSA was added at the final concentration ranging from 1 nm to
10 nM to the differentiation medium for five days as indicated. Please note that TSA dose dependently increases the DE marker expression. Data are
expressed as mean fold change 6 SD. A: Activin A; 3a:Wnt3a.
doi:10.1371/journal.pone.0027965.g007
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signaling is required only during late stages of Activin A-induced
development of Sox17-expressing endoderm cells [35]. Wnt3a
treatment alone does not significantly affect miRNA expression.
We noticed that there were many miRNAs, such as mir-340-3p,
mir-340-5p, mir-1896, mir-546, and mir-301b, whose expression
were not significantly affected by Activin A or Wnt3a alone at
progression or maturation stages, but regulated by Activin A and
Wnt3a co-treatment. Interestingly, all of these miRNAs were
synergistically down-regulated in Activin A and Wnt3a treated
samples. The functions of these synergistically down-regulated
miRNAs in DE differentiation warrant further detailed charac-
terization. Moreover, although the synergistically regulated
miRNAs upon Activin A and Wnt3a treatment could be validated
by RT-qPCR analyses, we found the expression pattern of
primary miRNA do not have this pattern (data not shown), which
suggested that Activin A and Wnt 3a might mainly affect miRNA
processing but not their expression per se.
Our functional analyses revealed that many putative pathways
were significantly enriched by synergistically regulated miRNAs.
Although, synergistically regulated miRNAs were not completely
over-lapped between DE progression and maturation stage, most
of the pathways they supposedly regulate were over-lapped,
suggesting that Wnt3a plays a consistent role in DE progression
and maturation, but through different miRNAs. Among the
putative pathways, TGF-beta, Notch and FGF pathways, have
been reported to be involved in DE formation in vitro and in
vivo[36–38], suggesting that Wnt3a may target multiple pathways
to promote DE differentiation from mouse ESCs.
Importantly, our pathway analysis on the synergistically
regulated miRNAs revealed the possible involvement of Hdac in
DE differentiation. Modification of chromatin by epigenetic
regulatory mechanisms, including histone acetylation, deacetyla-
tion and methylation, is considered as an important mechanism
for stem cell pluripotency and differentiation. Hdacs have been
reported to play important roles governing stem cell aging and
differentiation by regulating genes and miRNAs expression.
Moreover, recent studies revealed that Hdac forms a complex
with beta-catenin and regulates beta-catenin localization [39,40],
suggesting cross-talk between Hdacs and Wnt downstream
pathways. We examined publically available microarray data
and found that the expression level of Sox17 is significantly up-
regulated in Hdac1 knockout ESCs when compared to wild type
cells [41]. Two Hdac library derived small molecules could
significantly induce DE differentiation from mouse and human
ESCs [25]. There are no direct evidences for Hdac involvement in
Wnt3a-induced DE differentiation. In this report, we demonstrat-
ed that Wnt3a increases histone H3K9/K27 acetylation levels in
Activin A-induced DE, which could be partially mimicked by
forced expression of a subset of miRNAs. Inhibiting Hdac activity
promoted Activin A-induced DE differentiation. Moreover, Sox17
and Foxa2 promoters are indeed acetylated, indicating a
molecular cross talk among Wnt3a, Hdac activity, gene expression
and DE differentiation. However, how Wnt3a regulates Hdac
activity and how Hdacs affect DE differentiation and which
Hdac(s) is mainly involved in this process are key questions that
need further investigation.
In recent years, researches suggested that Hdac inhibition
accelerates the early events of stem cell differentiation [42].
Inhibiting Hdac activity could promote osteogenic differentiation,
neural cells differentiation, and myocardial differentiation, respec-
tively [30,43,44]. We noticed that treatment of TSA alone also
increased other germ line layer marker expression such as Cdx2,
etc (data not shown). Together with previous studies showing that
Hdacs are involved in neural cell differentiation [43], it is likely
that inhibiting Hdacs might open chromatin and render cells the
flexibility allowing stem cell differentiation. The roles of Hdac on
DE differentiation maybe only permissive but not instructive and it
might not be lineage-specific either. A very recent report suggested
that pre-treatment of TSA increases DE differentiation from
human ES cells, which also supports the current hypothesis [45].
Mouse embryonic development is a good model system to
understand human embryo and organ development. They share
some common mechanisms. We also examined whether miRNAs
involved in mouse DE differentiation also regulate human DE
differentiation from human ESCs. We compared our results with
previously published miRNAs data about human DE differentiation
[18,19], and found that there are many miRNAs over-lapping
between mouse and human data, such as mir-196a/b, let-7e and so
on, suggesting the molecular conservativeness between human and
mouse DE differentiation in terms of miRNA expression.
In summary, miRNAs are emerging as key regulators for ESCs
self-renewal and differentiation. Genome wide miRNA expression
profiling could reveal novel molecular insights into DE differen-
tiation. The involvement of histone acetylation in DE differenti-
ation uncovered by miRNA profiling and pathway analyses
established a regulatory cascade from extracellular cytokine
treatment to miRNA expression to histone modification in cell
nuclei. Our results also support a new venue to increase DE
differentiation for regenerative medicine through inhibition of
Hdac activity.
Supporting Information
Figure S1 Hierarchal clustering (A) and PCA (B) anal-
yses of raw data of miRNA profiling. The raw data was
normalized in GeneSpring, subsequent clustering was performed
using R, and PCA using GeneSpring.
(TIF)
Figure S2 Known DE specific miRNA expression during
Activin A and Wnt3a induced DE differentiation. Mouse
ESCs were treated with 100 ng/ml Activin A, 50 ng/ml Wnt3a,
or 100 ng/ml Activin A plus 50 ng/ml Wnt3a as indicated. The
differentiated cells samples were collected at day 5 of differenti-
ation for miRNA expression analysis using Taqman RT-qPCR.
The expression of two miRNAs identified in human DE
differentiation, mir-125a-5p and mir-let-7e, were analyzed as
presented. Data are expressed as mean fold change 6 SD. A:
Activin A; 3a:Wnt3a.
(TIF)
Figure S3 RT-qPCR examines selected miRNAs expres-
sion in differentiated mouse ESCs. Mouse ESCs were
treated with 100 ng/ml Activin A, 50 ng/ml Wnt3a, or 100 ng/
ml Activin A plus 50 ng/ml Wnt3a as indicated. The differenti-
ated cell samples were collected at day 5 of differentiation for
miRNA expression analysis using Taqman RT-qPCR. Data are
expressed as mean fold change 6 SD. A:Activin A; 3a:Wnt3a.
(TIF)
Figure S4 RT-qPCR examines miRNAs expression in
pooledmiRNAover-expresseddifferentiatedmouseESCs.
Mouse ESCs were treated with100 ng/ml Activin A for three days,
then transfected with pooled miRNAs to allow further differentiation
for 2 more days. Cel-miR-67 was used as a negative control. The
differentiated cell samples were collected at day 5 of differentiation
for miRNA expression analysis using Taqman RT-qPCR. Data are
e x p r e s s e da sm e a nf o l dc h a n g e6 SD. A:Activin A; 3a:Wnt3a.
(TIF)
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PLoS ONE | www.plosone.org 11 November 2011 | Volume 6 | Issue 11 | e27965Figure S5 RT-qPCR examines miRNAs expression in
pooled miRNA inhibitor over-expressed differentiated
mouse ESCs. Mouse ESCs were treated with100 ng/ml Activin
A and 50 ng/ml Wnt3a for three days, then transfected with
pooled miRNAs inhibitors to allow further differentiation for 2
more days. Cel-miR-67 inhibitor was used as a negative control.
The differentiated cell samples were collected at day 5 of
differentiation for miRNA expression analysis using Taqman
RT-qPCR. Data are expressed as mean fold change 6 SD.
A: Activin A; 3a:Wnt3a.
(TIF)
Figure S6 Consensus miRNA binding sites in the 39 UTR
region of Hdac7 and Hdac9. A. The consensus miRNA
binding sites in the 39 UTR region of Hdac7; B. The consensus
binding miRNA sites in the 39 UTR region of Hdac9. Red: mir-
338-5p binding site; Yellow: mir-181c binding site; Blue: mir-
196 a/mir-196b binding site.
(TIF)
Figure S7 RT-qPCR examination of Hdac expression in
pooled miRNA over-expressed differentiated mouse
ESCs. Mouse ESCs were treated with100 ng/ml Activin A for
three days, then transfected with pooled miRNAs to allow further
differentiation for 2 more days. Cel-miR-67 was used as a negative
control. The differentiated cell samples were collected at day 5 of
differentiation for HDACs expression analysis using RT-qPCR.
Data are expressed as mean fold change 6 SD. A: Activin A;
3a:Wnt3a.
(TIF)
Methods S1 miRNA over-expression protocol.
(DOC)
Table S1 Primers sequences. Listed are the primer sequenc-
es for qPCR analyses and the miRNA Taqman assay IDs. The
PCR primers were synthesized from Invitrogen (Carlsbad, USA).
All miRNA Taqman assays were purchased from ABI (Foster City,
USA).
(DOC)
Table S2 Differentially expressed genes in all samples.
Mouse ESCs were treated with 100 ng/ml Activin A, 50 ng/ml
Wnt3a, or 100 ng/ml plus 50 ng/ml Wnt3a, and the samples
were collected and profiled at 1 day, 3 days, and 5 days after
treatment. The differentially expressed miRNAs were identified by
using ANOVA test under FDR ,0.05. Total of 386 differentially
expressed miRNAs were identified.
(XLS)
Table S3 Differentially expressed miRNAs at day3
samples. Identification of differentially expressed miRNAs was
described in the methods section. 90 differentially expressed
miRNAs under the cutoff as FDR ,0.05 and fold.2o r,0.5
were identified from the 3 day samples.
(XLS)
Table S4 Differentially expressed miRNAs at day5
samples. Identification of differentially expressed miRNAs was
described in the methods section. 118 differentially expressed
miRNAs under the cutoff as FDR ,0.05 and fold.2o r,0.5
were identified from the 5 day samples.
(XLS)
Table S5 Enriched pathways of synergistically regulat-
ed miRNAs at DE progression stages. GeneGo pathway
analysis of putative targeted genes was performed on the
synergistically regulated miRNAs at the DE progression stage.
300 pathways were significantly enriched.
(DOC)
Table S6 Enriched pathways of synergistically regulat-
ed miRNAs at DE maturation stages. GeneGo pathway
analysis of putative targeted genes was performed on the
synergistically regulated miRNAs at the DE maturation stage.
252 pathways were significantly enriched.
(DOC)
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